Atreca, Inc.

Atreca, Inc. is a biotechnology company focused on developing novel therapeutics with a deep understanding of the human immune response, particularly in the field of innovative cancer immunotherapeutics. Founded in 2010, Atreca leverages its Immune Repertoire Capture™ (IRC™) technology to gain unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. The company was created by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. Atreca recently received a significant $125.00MPost-IPO Equity investment on 15 July 2020. Located in the United States, Atreca is actively seeking talented individuals dedicated to making a positive impact on human health. The company's open positions can be found at: http://www.atreca.com/careers/.